Method of detecting cancer using delta-catenin

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

08058020

ABSTRACT:
The present invention provides a method for detecting or screening for the presence of cancer in a subject. The method comprises obtaining, providing or collecting a tissue or fluid sample (such as a urine sample) from said subject, and then determining the presence or absence of delta-catenin in said sample, or increased levels of delta-catenin in said sample as compared to a normal or control subject. The presence of delta-catenin in said sample, or increased levels of delta-catenin in said sample, indicating said subject is afflicted with or at least at risk of developing cancer.

REFERENCES:
patent: 6258929 (2001-07-01), Kosik et al.
Burger et al, Int J. Cancer,100: 228-237, 2002, IDS, p. 3, Sep. 26, 2008.
Zhang et al, J Pathology, 222:76-88, 2010.
Lu et al, The Prostate, 69:411-418, 2009.
Mesh word search result, 2010.
S. Kirchheimer, High PSA Level? Check it Again (May 27, 2003).
National Cancer Institute, Fact Sheet: The Prostate-Specific Antigen (PSA) Test: Questions and Answers (Aug. 21, 2007).
A Krist et al., Should you get a PSA test? A Patient Doctor Decision (2007).
W. Catalona, PSA Screening: It's a Must (2007).
International Search Report and Written Opinion for PCT Application No. PCT/US2004/19895, Mailed May 2, 2006.
Burger, Michelle Jane et al. (2002) “Expression Analysis of δ-Catenin and Prostate-Specific Membrane Antigen: Their Potential as Diagnostic Markers for Prostate Cancer.”Int. J. Cancer: 100, 228-237.
Kim, Kwonseop et al. (2002) “Dendrite-like Process Formation and Cytoskeletal Remodeling Regulated by δ-Catenin Expression.”Experimental Cell Research, 275, 171-184.
Lu, Q. et al. (2002) “Brain Armadillo Protein δ-Catenin Interacts with Abl Tyrosine Kinase and Modulates Cellular Morphogenesis in Response to Growth Factors”Journal of Neuroscience Research: 67, 618-624.
MeSH word search result. delta catenin. Printed Jan. 16, 2008.
Thoreson Ma et al. Altered expression of the catenin p120 in human cancer: implications for tumor progression. Differentiation. Dec. 2002; 70(9-10): 583-589. Abstract.
Skoudy A et al. p120-catenin expression in human colorectal cancer. Int J Cancer. Sep. 27, 1996; 68(1): 14-20. Abstract.
Dillon Da et al. The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Am J Pathol. Jan. 1998; 1521(1): 75-82. Abstract.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of detecting cancer using delta-catenin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of detecting cancer using delta-catenin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting cancer using delta-catenin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4302620

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.